Journal
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
Volume 50, Issue 9, Pages 998-1005Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/JOM.0b013e3181715111
Keywords
-
Categories
Funding
- Ortho-McNeil Janssen Scientific Affairs, L.LC.
Ask authors/readers for more resources
Objective: To assess the health care utilization and cost of illness for osteoarthritis (OA) patients taking Pain medications. Specifically, the goats were to estimate the direct health care and indirect costs of OA. Methods: A claims database of privately insured patients was used to identify OA patients. Prescription drug pain treatments included tramadol, cyclooxygenase-II inhibitors, and nonsteroldal anti-inflammatary drugs. Mean annual per patient costs were calculated from an employer's perspective. Results: OA patients were prescribed multiple drugs simultaneously and/or sequentially to manage pain. OA patients had a number of prevalent comorbid conditions. Average annual direct medical, drug, and indirect work loss costs were $8601, $2941, and $4603, respectively. Conclusions: There was a substantial payer burden associated with OA resulting from the drug, medical, and disability costs and OA-related comorbidities and high concomitant medication utilization.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available